Is Adaptimmune Therapeutics plc (ADAP) a Buy, Sell, or Hold?
NASDAQ : ADAP
Adaptimmune Therapeutics plc
$0.0485 USD
$0.0 (-3.0%)
- Volume
- 1.68M
- Average Volume
- 110.64M
- Market Capitalization
- $75.16M
- P/E Ratio
- -0.16
- Dividend Yield
- 0.00%
- Price Target
- $3.00
- Year High
- $0.86
- Year Low
- $0.02
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $1.52
Analyst Consensus Summary
Consensus Rating
N/A
16 Analysts
Rating Score
0/5
Recommendation Strength
Upside/Downside
-98.4%
vs Current Price
Price Target
$3.00
Average TargetPrice Target Range
Lowest Target
$1.00
-95.2% DOWNSIDE
Average Target
$3.00
Median Estimate
Highest Target
$4.00
-98.8% DOWNSIDEAnalyst Breakdown
Overall Consensus: Buy | Total Analysts: 16
| Strong Buy | Buy | Hold | Sell | Strong Sell |
|---|---|---|---|---|
| 0 | 9 | 4 | 3 | 0 |
Analyst Ratings (Detailed)
| Analyst Company | Analyst Name | Price Target | Price When Posted | Date | Upside/Downside |
|---|---|---|---|---|---|
| H.C. Wainwright | Arthur He | $4 | $1.37 | 2024-07-30 02:07 AM | 192.0% |
| Scotiabank | George Farmer | $3.15 | $1.01 | 2024-05-30 03:11 AM | 211.9% |
| Mizuho Securities | Graig Suvannavejh | $3 | $1.2 | 2024-05-17 02:42 AM | 150.0% |
| Barclays | Peter Lawson | $1 | $1.2 | 2024-05-16 10:45 AM | -16.7% |